These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31491796)

  • 21. Combination of Intravenous and Intra-Articular Application of Tranexamic Acid and Epsilon-Aminocaproic Acid in Primary Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.
    Zheng C; Ma J; Xu J; Si H; Liu Y; Li M; Shen B
    Orthop Surg; 2023 Mar; 15(3):687-694. PubMed ID: 36575630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial.
    Chen X; Cao X; Yang C; Guo K; Zhu Q; Zhu J
    J Arthroplasty; 2016 Nov; 31(11):2471-2475. PubMed ID: 27167769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.
    Wang D; Zhu H; Meng WK; Wang HY; Luo ZY; Pei FX; Li Q; Zhou ZK
    BMC Musculoskelet Disord; 2018 Mar; 19(1):85. PubMed ID: 29544472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial.
    Hill J; Magill P; Dorman A; Hogg R; Eggleton A; Benson G; McFarland M; Murphy L; Gardner E; Bryce L; Martin U; Adams C; Bell J; Campbell C; Agus A; Phair G; Molloy D; Mockford B; O'Hagan S; Beverland D
    Trials; 2018 Jul; 19(1):413. PubMed ID: 30064517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of epsilon aminocaproic acid (EACA) as an antihemorrhagic drug in bilateral one stage total knee arthroplasty: A double-blind randomized controlled trial.
    Tripathy SK; Rao PB; Nanda SN; Nayak C; Samal BP; Jain M; Srinivasan A; Hota D
    Knee; 2020 Jan; 27(1):229-234. PubMed ID: 31882387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
    Lošťák J; Gallo J; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.
    Wang D; Wang HY; Cao C; Li LL; Meng WK; Pei FX; Li DH; Zhou ZK; Zeng WN
    Sci Rep; 2018 Sep; 8(1):13579. PubMed ID: 30206267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    Fillingham YA; Kayupov E; Plummer DR; Moric M; Gerlinger TL; Della Valle CJ
    J Arthroplasty; 2016 Sep; 31(9 Suppl):26-30. PubMed ID: 27113948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty.
    Wu C; Tan C; Wang L
    Arch Orthop Trauma Surg; 2020 Dec; 140(12):2071-2075. PubMed ID: 32862267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
    Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
    J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The optimal protocol to reduce blood loss and blood transfusion after unilateral total knee replacement: Low-dose IA-TXA plus 30-min drain clamping versus drainage clamping for the first 3 h without IA-TXA.
    Park JH; Choi SW; Shin EH; Park MH; Kim MK
    J Orthop Surg (Hong Kong); 2017; 25(3):2309499017731626. PubMed ID: 28950794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial.
    Wang D; Luo ZY; Yu ZP; Liu LX; Chen C; Meng WK; Yu QP; Pei FX; Zhou ZK; Zeng WN
    J Thromb Haemost; 2018 Dec; 16(12):2442-2453. PubMed ID: 30430724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    Dai WL; Zhou AG; Zhang H; Zhang J
    J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
    Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
    BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Optimal Dose, Efficacy and Safety of Tranexamic Acid and Epsilon-Aminocaproic Acid to Reduce Bleeding in TKA: A Systematic Review and Bayesian Network Meta-analysis.
    Zheng C; Ma J; Xu J; Li M; Wu L; Wu Y; Liu Y; Shen B
    Orthop Surg; 2023 Apr; 15(4):930-946. PubMed ID: 36878889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial.
    Aguilera X; Martínez-Zapata MJ; Hinarejos P; Jordán M; Leal J; González JC; Monllau JC; Celaya F; Rodríguez-Arias A; Fernández JA; Pelfort X; Puig-Verdie Ll
    Arch Orthop Trauma Surg; 2015 Jul; 135(7):1017-25. PubMed ID: 25944156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
    Yuan X; Li B; Wang Q; Zhang X
    J Arthroplasty; 2017 Sep; 32(9):2738-2743. PubMed ID: 28455182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Nielsen CS; Jans Ø; Ørsnes T; Foss NB; Troelsen A; Husted H
    J Bone Joint Surg Am; 2016 May; 98(10):835-41. PubMed ID: 27194493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.